Skip to main content

Table 2 Mean dietary intakes of study participants at baseline, weeks 5, 9 and 12 of the study1

From: Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients

  Placebo group
(n = 30)
Vitamin D plus probiotic group (n = 30) P2
Energy (kcal/d) 2540 ± 184 2488 ± 147 0.23
Carbohydrates (g/d) 347.9 ± 42.1 337.9 ± 43.2 0.36
Protein (g/d) 89.5 ± 12.9 85.7 ± 11.2 0.23
Fat (g/d) 92.6 ± 13.4 92.2 ± 12.2 0.91
SFAs (g/d) 26.4 ± 5.6 26.3 ± 5.8 0.85
PUFAs (g/d) 30.0 ± 8.4 28.9 ± 6.9 0.61
MUFAs (g/d) 25.0 ± 5.6 24.4 ± 5.8 0.68
Cholesterol (mg/d) 188.6 ± 97.0 222.6 ± 119.7 0.18
TDF (g/d) 20.7 ± 5.2 18.9 ± 4.8 0.18
Magnesium (mg/d) 325.1 ± 88.3 295.8 ± 69.7 0.15
Zinc (mg/d) 11.1 ± 3.0 10.4 ± 2.8 0.34
Manganese (mg/d) 2.4 ± 0.8 2.3 ± 0.6 0.44
Calcium (mg/d) 1203.1 ± 161.9 1145.6 ± 231.3 0.27
Vitamin D (μg/d) 2.8 ± 0.7 2.6 ± 0.5 0.24
  1. 1Data are means± SDs
  2. 2Obtained from independent t-test
  3. MUFAs, monounsaturated fatty acids; PUFAs, polyunsaturated fatty acids; SFAs, saturated fatty acids; TDF, total dietary fiber